LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Insurance Execs Win Obamacare Jackpot
Company News

Insurance Execs Win Obamacare Jackpot

June 11, 2014 2 min read Premium comments

Advertisement

Insurance Execs Win Obamacare Jackpot
Aetna CEO Mark Bertolini/Wikimedia Commons, World Economic Forum and Adam Nadel
Secondary

Life is good at the top of the healthcare food chain.

The chief executives of the 11 largest for-profit insurers earned more than $125 million in total compensation in 2013.

Aetna’s Bertolini Wins

Of the 11 insurers—Aetna, Centene, Cigna, Health Net, Humana, Molina, Triple-S Management Corporation, UnitedHealth, Universal American, WellCare and WellPoint—Aetna CEO Mark Bertolini earned the most, taking home $30.7 million in 2013—an increase of 131% from the year before, according to a recent FierceHealthPayer report.

In contrast, the administrator of Centers for Medicare and Medicaid Services (CMS), the biggest insurer was paid $165, 300.

That’s the biggest Obamacare jackpot for any health insurance executive since passage of the Affordable Care Act and exceeded the compensation of the next two highest paid health insurer CEOs combined. Centene CEO Michael Neidorff took home $14.5 million last year, up 71% from the previous year, according to Healthcare-Now, a non-profit group that advocates for a single-payer system.

Almost all of the 11 insurers saw their revenue and profits rise last year and several are predicting that they’ll likely bring in higher-than-expected profits this year. Those predictions come as medical claims are rising as more consumers bought coverage from the health insurance exchanges.

Average Comp Up 19%

Advertisement

The average pay for Fortune 500 health insurance CEOs grew from $11.6 million in 2012 to $13.9 million in 2013. And for the top nine insurers, CEOs saw their average compensation packages increase by more than 19% last year, while other insurers more than doubled their CEO pay.

Top CMS Administrator

“In contrast, the top administrator of Medicare —our public, universal health plan for all seniors, which is more efficient, provides better financial protection, and receives higher marks from patients than private health insurers—is paid less than $200, 000 per year. The culture of excess at these for-profit corporations is incompatible with the goals of an efficient, ethical health care system, where every dollar diverted from patient care represents a loss of access for real families, ” said Benjamin Day, director of organizing at Healthcare-NOW.

Day continued: “We face the highest healthcare costs and have among the worst health outcomes of any country in the developed world because we allow private health insurers and dozens of other intermediaries to act as for-profit middlemen in the health care system. Although many backers of the Affordable Care Act said it would rein in insurance company excesses, the law clearly hasn’t curtailed top executive pay.”

Hey, it’s tough to manage all that risk while finding new ways to deny coverage and buy up hospitals.

Top Paid Insurance CEOs

" data-large-file="https://i0.wp.com/ryortho.com/wp-content/uploads/2014/06/Insurance_2013CEOPayChart_WEB.jpg?fit=730%2C495&ssl=1" src="https://i0.wp.com/ryortho.com/wp-content/uploads/2014/06/Insurance_2013CEOPayChart_WEB.jpg?resize=730%2C495&ssl=1" alt="2013 CEO PayChart" width="730" height="495">
React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy